نتائج البحث

Immunotherapy for advanced or metastatic urothelial carcinoma: an abridged Cochrane review.

• Authors : Maisch, Philipp^1,2 (AUTHOR) ; Hwang, Eu Chang³ (AUTHOR); Kim, Kwangmin⁴ (AUTHOR)

• Source: BJU International. Oct2024, Vol. 134 Issue 4, p541-550. 10p.

تفاصيل العنوان

First‐line immunotherapy of metastatic renal cell carcinoma: an updated network meta‐analysis including triplet therapy.

• Authors : Yanagisawa, Takafumi^1,2 (AUTHOR); Kawada, Tatsushi^1,3 (AUTHOR); Bekku, Kensuke^1,3 (AUTHOR)

• Source: BJU International. Sep2024, Vol. 134 Issue 3, p323-336. 14p.

تفاصيل العنوان

Diagnostic and prognostic genomic aberrations in upper tract urothelial carcinoma can be identified in focal barbotage samples

• Authors : Axelsson, TA; Syden, F; Eisfeldt, J

• Source: BJU INTERNATIONAL. 135(5):792-801

تفاصيل العنوان

Improving detection of carcinoma in situ in bladder cancer: urinary cytology vs the Xpert® BC Monitor.

• Authors : Haas, Maximilian¹ (AUTHOR) ; Kriegmair, Maximilian C.^2,3 (AUTHOR); Breyer, Johannes¹ (AUTHOR)

• Source: BJU International. Nov2024, Vol. 134 Issue 5, p755-762. 8p.

تفاصيل العنوان

Gemcitabine/nab‐paclitaxel vs gemcitabine/carboplatin for advanced urothelial carcinoma.

• Authors : An, Xin¹ (AUTHOR); Xue, Cong¹ (AUTHOR); Chen, Meiting¹ (AUTHOR)

• Source: BJU International. Jul2024, Vol. 134 Issue 1, p63-71. 9p.

تفاصيل العنوان

Assessment of eligibility criteria in renal cell carcinoma trials evaluating systemic therapy.

• Authors : Castro, Daniela V.¹ (AUTHOR); Prajapati, Sweta R.¹ (AUTHOR); Feng, Matthew I.¹ (AUTHOR)

• Source: BJU International. Mar2024, Vol. 133 Issue 3, p297-304. 8p.

تفاصيل العنوان

Impact of lymphovascular invasion on survival in surgically treated upper tract urothelial carcinoma: a nationwide analysis.

• Authors : Cirulli, Giuseppe Ottone^1,2 (AUTHOR); Corsi, Nicholas¹ (AUTHOR); Rakic, Ivan¹ (AUTHOR)

• Source: BJU International. May2024, Vol. 133 Issue 5, p555-563. 9p.

تفاصيل العنوان

Fluorescence-guided surgery using cetuximab-800CW in patients with penile carcinoma.

• Authors : Nijboer TS; Department of Oral and Maxillofacial Surgery, University Medical Centre Groningen, Groningen, The Netherlands.; van der Fels CAM

Subjects: Cetuximab*/Cetuximab*/Cetuximab*/administration & dosage ; Penile Neoplasms*/Penile Neoplasms*/Penile Neoplasms*/surgery ; Penile Neoplasms*/Penile Neoplasms*/Penile Neoplasms*/pathology

• Source: BJU international [BJU Int] 2024 Aug; Vol. 134 (2), pp. 268-275. Date of Electronic Publication: 2024 Apr 24.Publisher: Blackwell Science Country of Publication: England NLM ID: 100886721 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

تفاصيل العنوان

Is there a role for pembrolizumab beyond progression in urothelial carcinoma?

• Authors : Taguchi S; Department of Urology, Graduate School of Medicine, The University of Tokyo, Bunkyo-ku, Tokyo, Japan.; Kawai T

Subjects: Antibodies, Monoclonal, Humanized*/Antibodies, Monoclonal, Humanized*/Antibodies, Monoclonal, Humanized*/therapeutic use ; Carcinoma, Transitional Cell*/Carcinoma, Transitional Cell*/Carcinoma, Transitional Cell*/drug therapy ; Carcinoma, Transitional Cell*/Carcinoma, Transitional Cell*/Carcinoma, Transitional Cell*/pathology

• Source: BJU international [BJU Int] 2024 Jul; Vol. 134 (1), pp. 43-44. Date of Electronic Publication: 2023 Dec 18.Publisher: Blackwell Science Country of Publication: England NLM ID: 100886721 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

تفاصيل العنوان

Localised non‐metastatic sarcomatoid renal cell carcinoma: a 31‐year externally verified study.

• Authors : Blum, Kyle A.¹ (AUTHOR); Silagy, Andrew W.¹ (AUTHOR); Knezevic, Andrea² (AUTHOR)

• Source: BJU International. Feb2024, Vol. 133 Issue 2, p169-178. 10p.

تفاصيل العنوان